Development of a psilocin immunoassay for serum and blood samples.
C Albers, H Köhler, M Lehr, B Brinkmann, J Beike
Index: Int. J. Legal Med. 118(6) , 326-31, (2004)
Full Text: HTML
Abstract
After the immunisation of rabbits with a psilocin-specific immunogen, polyclonal antisera were obtained. With these antisera a competitive, heterogeneous radioimmunoassay for the detection of psilocin was developed. As tracer a derivative of psilocin was synthesised, which contained a tritiated CH(3) group. The antisera showed a specific reaction with psilocin. The cross-reactivity of structurally related endogenous substances like serotonin, tryptophan and tyrosine was below 0.01%. Also common drugs of abuse (Delta(9)-tetrahydrocannabinol, cocaine, morphine, amphetamine) showed negligible cross-reactivity (0.01-2%). Only tricyclic neuroleptics with a (dimethylamino)ethyl side-chain showed some cross-reactivity (20%). Spiked serum and blood samples were analysed with this new immunoassay and the results obtained were compared with the values measured with a validated GC-MS method.
Related Compounds
Related Articles:
2015-03-01
[J. Anal. Toxicol. 39(2) , 126-9, (2015)]
2010-03-01
[Drug Metab. Dispos. 38(3) , 386-95, (2010)]
2011-09-01
[Drug Test. Anal. 3(9) , 594-6, (2011)]
2004-08-01
[Ann. Emerg. Med. 44(2) , 114-20, (2004)]
2013-08-01
[Ther. Drug Monit. 35(4) , 420-42, (2013)]